IL6 and metabolic syndrome: Metabolic syndrome (MetS) is defined as a state of low-grade chronic inflammation, evidenced by elevated serum levels of pro-inflammatory cytokines like tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) [76].